At 11:04 IST on BSE, Cadila Healthcare put on 1.17% to Rs. 697.10, subsequent to the company rolled out the Pramipexole tablets in manifold power in the United States. The group made this declaration, today in the trading hours, 14 October 2010.

In the meantime, the BSE Sensex was moving up by or 0.07% at 20702.69 or 14.81 points. On BSE, 5,366 equities were dealt in counteract as adjacent to a standard daily amount of 29,452 shares in the precedent one quarter.

The stock strikes in height of Rs. 706.95 and a low down of Rs. 691 so distant during the day. The stock had strike a record high-pitched of Rs. 725 on 1 October 2010 and a 52-week low down of Rs. 340.67 on 14 October 2009.

The big -cap equity had outperformed the market during the precedent one month till 13 October 2010, elevating the 12.32% contrasted with the Sensex's earnings of 7.70%. It had underperformed the market in earlier period one quarter, benefitting 5.73% as in opposition to 15.02% hike in the Sensex.

With an equity capital of Rs. 102.17 crore the group has a Face value per share is Rs. 5.

Pramipexole tablet come under the central nervous system (CNS) domain and is utilized for curing Parkinson's ailment.